
Biological and Pharmaceutical Bulletin p. 890 - 892 (1996)
Update date:2022-08-04
Topics:
Kawasaki, Koichi
Inoue, Sachie
Okada, Yoshio
Iguchi, Shin
Okamoto, Hiroshi
Gln-Val-Val-Ala-Gly is a sequence which is common in cysteine protease inhibitors. Poly(ethylene glycol) hybrids of Gln-Val-Val-Ala-Gly analogs were prepared by the solid phase method by fluorenylmethyloxycarbonyl chemistry. The hybrid formation of Gln-Val-Val-Ala-Gly resulted in improvement of the solubility and also in enhancement of the inhibitory effect of the peptide on papain. In additiohn, the hybrid formation of Gly-Val-Val-Ala-Gly analogs resulted in the enhancement of the inhibitory effect of the peptide analogs.
View MoreContact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Jiangsu Hualun Chemical Industry Co., Ltd
website:http://www.hualunchem.com
Contact:+86-0514-86464168 86507985
Address:39# Middle Renmin Road, Dinghuo Town
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551413
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Chengdu King-tiger Pharm-chem. Tech. Co., Ltd
Contact:028-85317716
Address:Tianfu Life Science Park, No. 88 South Keyuan Road, Gaoxin District, Chengdu City, Sichuan Province, PRC.
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Doi:10.1016/S0040-4020(02)00436-2
(2002)Doi:10.1016/S0960-894X(98)00047-X
(1998)Doi:10.1039/c39940002443
(1994)Doi:10.1021/ja00110a013
(1995)Doi:10.1007/BF02036199
(1994)Doi:10.1039/c4cc00118d
(2014)